Duration of device-detected subclinical atrial fibrillation and occurrence of stroke in ASSERT
Duration of device-detected subclinical atrial fibrillation and occurrence of stroke in ASSERT
I. V. van Gelder,J. Healey,9 Authors,S. Connolly
2017 · DOI: 10.1093/eurheartj/ehx042
European Heart Journal · 554 Citations
TLDR
SCAF duration >24 h was associated with a significant increased risk of subsequent stroke or systemic embolism, and patients with SCAF between 6 min and 24’h was not significantly different from patients without SCAF.
